Severe Aplastic Anaemia Working Party (SAAWP)
Study type:
Study number:
2007-00902-55
Type of Stem Cell Treatment:
Diseases:
Bone marrow failure
Short title:
RATGAA07
Primary objective:
Assess tolerability and efficacy of rabbit ATG (Thymoglobuline®) with CSA in the first line treatment of patients with acquired SAA, and patients with NSAA
Key inclusion criteria:
>=16years (18 in DE + CH)
Country:
France
Germany
Italy
Saudi Arabia
Switzerland
United Kingdom
Principal investigator:
Judith Marsh
EBMT Study coordinator:
Alain Barrois